Visual Abstract: Efficacy of Epigallocatechin-3-Gallate on Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy | JAMA Dermatology

Disclaimer: The content, article(s), education, opinions, products and/or services discussed and/or mentioned herein are: Not intended for the general public; Not considered medical, legal, financial, accounting or other professional advice; and to educate physicians, healthcare business leaders and/or healthcare professionals about relevant healthcare news.


JAMA Dermatology

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, JUNE 1, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Free access to the full-text article: https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2022.1736?guestAccessKey=b09035d2-68c6-4a2f-8bdf-d4ae3721b7c6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060122

Visual Abstract

Authors: Ligang Xing, M.D., Ph.D., of the Shandong First Medical University and Shandong Academy of Medical Sciences in Shandong, China, is the corresponding author.

(doi:10.1001/jamadermatol.2022.1736)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Next Post

JAMA: Outcomes Following Taxation of Sugar-Sweetened Beverages

Sat Jun 18 , 2022
Disclaimer: The content, article(s), […]